Brief: Pangen Biotech receives patent
26/04/2018 09:53
April 26 (Reuters) - Pangen Biotech Inc 222110.KQ :
* Says it received patent on April 26, for antibodies
cross-reactive to Human and Mouse Sema3A and Uses thereof
* Patent number is 10-2016-0123233
Source text in Korean : https://goo.gl/9Xu8wm
Further company coverage: 222110.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))